DJ_Dave writes and performs dance music with code. Her debut album, Hardcore Software, combines tech optimism with the open source spirit of an algorave.
Melbourne kidney disease drug developer Dimerix has drawn $17 million from a $34 million loan facility as its lead candidate goes through a pivotal Phase 3 trial. Dimerix says the new funds and its ...
San Francisco, California--(Newsfile Corp. - September 22, 2026) - DIMERx, Inc., a clinical-stage biopharmaceutical company developing novel dimer-based therapeutics, today announced that it has ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. NIH Support Expands Pipeline and Further Validates ...
"We are delighted with the support received from lenders across both Australia and the United States, reflecting growing confidence in Dimerix, our clinical programs and our mission to improve ...
MELBOURNE, Australia, Sept. 4, 2026 /PRNewswire/ -- Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results